Quadrant Capital Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,131
Closed -$20K 2792
2021
Q3
$20K Buy
+1,131
New +$20K ﹤0.01% 1255